Drug Type ASO |
Synonyms IONIS JBI1 2.5RX |
Target- |
Action modulators, inhibitors |
Mechanism Immunomodulators, Protein biosynthesis inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Phase 1 | United States | 21 Dec 2017 | |
| Autoimmune Diseases | Phase 1 | United States | 21 Dec 2017 |





